Literature DB >> 23682103

Reply to "Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays".

Lotfi Bounaadja, Jocelyne Piret, Nathalie Goyette, Guy Boivin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23682103      PMCID: PMC3716044          DOI: 10.1128/JCM.00545-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  12 in total

Review 1.  Epstein-Barr virus-recent advances.

Authors:  Karen F Macsween; Dorothy H Crawford
Journal:  Lancet Infect Dis       Date:  2003-03       Impact factor: 25.071

2.  Real-time PCR as a versatile tool for investigating the susceptibility of human herpesvirus 6 to antiviral agents.

Authors:  Muriel Macé; Chaysavanh Manichanh; Pascale Bonnafous; Stéphanie Précigout; David Boutolleau; Agnès Gautheret-Dejean; Henri Agut
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

3.  Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.

Authors:  J Luka; B Kallin; G Klein
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

Review 4.  Human herpesvirus 6: a clinical update.

Authors:  Danielle M Zerr
Journal:  Herpes       Date:  2006-05

5.  Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.

Authors:  D H Kedes; D Ganem
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 6.  Biology of Kaposi's sarcoma.

Authors:  B Ensoli; C Sgadari; G Barillari; M C Sirianni; M Stürzl; P Monini
Journal:  Eur J Cancer       Date:  2001-07       Impact factor: 9.162

7.  Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.

Authors:  Francesco Broccolo; Paolo Lusso; Mauro Malnati
Journal:  J Clin Microbiol       Date:  2013-06       Impact factor: 5.948

8.  Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines.

Authors:  T M Buttke; J A McCubrey; T C Owen
Journal:  J Immunol Methods       Date:  1993-01-04       Impact factor: 2.303

9.  Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.

Authors:  R Renne; W Zhong; B Herndier; M McGrath; N Abbey; D Kedes; D Ganem
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

10.  Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.

Authors:  Yan Sergerie; Guy Boivin
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.